title: NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.
abstract: Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are different manifestations of the same disease and managed in much the same way. The advent of novel CD20 monoclonal antibodies led to the development of effective chemoimmunotherapy regimens. More recently, small molecule inhibitors targeting kinases involved in a number of critical signaling pathways and a small molecule inhibitor of the BCL-2 family of proteins have demonstrated activity for the treatment of patients with CLL/SLL. These NCCN Guidelines Insights highlight important updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for CLL/SLL for the treatment of patients with newly diagnosed or relapsed/refractory CLL/SLL.
authors.affiliation: The University of Texas MD Anderson Cancer Center
authors.forename: William G
authors.initials: WG
authors.lastname: Wierda
authors.affiliation: Memorial Sloan Kettering Cancer Center
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Zelenetz
authors.affiliation: Robert H. Lurie Comprehensive Cancer Center of Northwestern University
authors.forename: Leo I
authors.initials: LI
authors.lastname: Gordon
authors.affiliation: Massachusetts General Hospital Cancer Center
authors.forename: Jeremy S
authors.initials: JS
authors.lastname: Abramson
authors.affiliation: Stanford Cancer Institute
authors.forename: Ranjana H
authors.initials: RH
authors.lastname: Advani
authors.affiliation: UCSF Helen Diller Family Comprehensive Cancer Center
authors.forename: C Babis
authors.initials: CB
authors.lastname: Andreadis
authors.affiliation: Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
authors.forename: Nancy
authors.initials: N
authors.lastname: Bartlett
authors.affiliation: The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
authors.forename: John C
authors.initials: JC
authors.lastname: Byrd
authors.affiliation: Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
authors.forename: Paolo
authors.initials: P
authors.lastname: Caimi
authors.affiliation: The University of Texas MD Anderson Cancer Center
authors.forename: Luis E
authors.initials: LE
authors.lastname: Fayad
authors.affiliation: Fox Chase Cancer Center
authors.forename: Richard I
authors.initials: RI
authors.lastname: Fisher
authors.affiliation: Huntsman Cancer Institute at the University of Utah
authors.forename: Martha J
authors.initials: MJ
authors.lastname: Glenn
authors.affiliation: Mayo Clinic Cancer Center
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Habermann
authors.affiliation: Massachusetts General Hospital Cancer Center
authors.forename: Nancy Lee
authors.initials: NL
authors.lastname: Harris
authors.affiliation: Roswell Park Cancer Institute
authors.forename: Francisco
authors.initials: F
authors.lastname: Hernandez-Ilizaliturri
authors.affiliation: Stanford Cancer Institute
authors.forename: Richard T
authors.initials: RT
authors.lastname: Hoppe
authors.affiliation: Memorial Sloan Kettering Cancer Center
authors.forename: Steven M
authors.initials: SM
authors.lastname: Horwitz
authors.affiliation: University of Michigan Comprehensive Cancer Center
authors.forename: Mark S
authors.initials: MS
authors.lastname: Kaminski
authors.affiliation: Duke Cancer Institute
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Kelsey
authors.affiliation: Stanford Cancer Institute
authors.forename: Youn H
authors.initials: YH
authors.lastname: Kim
authors.affiliation: Consultant
authors.forename: Susan
authors.initials: S
authors.lastname: Krivacic
authors.affiliation: Dana-Farber/Brigham and Women’s Cancer Center
authors.forename: Ann S
authors.initials: AS
authors.lastname: LaCasce
authors.affiliation: St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center
authors.forename: Michael G
authors.initials: MG
authors.lastname: Martin
authors.affiliation: City of Hope National Medical Center
authors.forename: Auayporn
authors.initials: A
authors.lastname: Nademanee
authors.affiliation: The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Porcu
authors.affiliation: Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
authors.forename: Oliver
authors.initials: O
authors.lastname: Press
authors.affiliation: University of Colorado Cancer Center
authors.forename: Rachel
authors.initials: R
authors.lastname: Rabinovitch
authors.affiliation: Vanderbilt-Ingram Cancer Center
authors.forename: Nishitha
authors.initials: N
authors.lastname: Reddy
authors.affiliation: UC San Diego Moores Cancer Center
authors.forename: Erin
authors.initials: E
authors.lastname: Reid
authors.affiliation: Yale Cancer Center/Smilow Cancer Hospital
authors.forename: Kenneth
authors.initials: K
authors.lastname: Roberts
authors.affiliation: University of Alabama at Birmingham Comprehensive Cancer Center
authors.forename: Ayman A
authors.initials: AA
authors.lastname: Saad
authors.affiliation: University of Alabama at Birmingham Comprehensive Cancer Center
authors.forename: Erin D
authors.initials: ED
authors.lastname: Snyder
authors.affiliation: Moffitt Cancer Center
authors.forename: Lubomir
authors.initials: L
authors.lastname: Sokol
authors.affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
authors.forename: Lode J
authors.initials: LJ
authors.lastname: Swinnen
authors.affiliation: Fred & Pamela Buffett Cancer Center
authors.forename: Julie M
authors.initials: JM
authors.lastname: Vose
authors.affiliation: Memorial Sloan Kettering Cancer Center
authors.forename: Joachim
authors.initials: J
authors.lastname: Yahalom
authors.affiliation: National Comprehensive Cancer Network
authors.forename: Mary A
authors.initials: MA
authors.lastname: Dwyer
authors.affiliation: National Comprehensive Cancer Network
authors.forename: Hema
authors.initials: H
authors.lastname: Sundar
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D058990:Molecular Targeted Therapy; D009367:Neoplasm Staging; D012008:Recurrence; D019233:Retreatment; D016896:Treatment Outcome